TECFIDERA - Articles and news items

Biogen Idec logo

Tecfidera® (dimethyl fumarate) approved in the European Union as a first-line oral treatment for multiple sclerosis

Industry news / 3 February 2014 / Biogen Idec

Biogen Idec to begin launching TECFIDERA in initial EU Countries in the coming weeks…

Biogen Idec logo

CHMP determines Dimethyl Fumarate in TECFIDERA® to be a new active substance in the European Union

Industry news / 22 November 2013 / Biogen Idec

This designation will provide 10 years of regulatory exclusivity for TECFIDERA in the European Union…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...